Literature DB >> 15098650

Myosin light chain composition in non-failing donor and end-stage failing human ventricular myocardium.

J van der Velden1, Z Papp, N M Boontje, R Zaremba, J W de Jong, P M L Janssen, G Hasenfuss, G J M Stienen.   

Abstract

The increased Ca(2+)-responsiveness in end-stage human heart failure cannot be attributed to contractile protein isoform changes, but rather is the complex resultant of changes in degree of phosphorylation of VLC-2 and TnI. Despite the decreased basal level of VLC-2 phosphorylation the response to VLC-2 dephosphorylation is enhanced in failing myocytes, which might result from differences in endogenous phosphorylation of thin and thick filament proteins between donor and failing hearts. Taken together decreased VLC-2 phosphorylation in end-stage human heart failure might represent a compensatory process leading to an improvement of myocardial contractility by opposing the detrimental effects of increased Ca(2+)-responsiveness of force and impaired Ca(2+)-handling on diastolic function.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15098650     DOI: 10.1007/978-1-4419-9029-7_1

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  14 in total

1.  Increased myocardial short-range forces in a rodent model of diabetes reflect elevated content of β myosin heavy chain.

Authors:  Charles S Chung; Mihail I Mitov; Leigh Ann Callahan; Kenneth S Campbell
Journal:  Arch Biochem Biophys       Date:  2013-09-04       Impact factor: 4.013

2.  Myosin heavy chain composition and the economy of contraction in healthy and diseased human myocardium.

Authors:  N A Narolska; S Eiras; R B van Loon; N M Boontje; R Zaremba; S R Spiegelen Berg; W Stooker; M A J M Huybregts; F C Visser; J van der Velden; G J M Stienen
Journal:  J Muscle Res Cell Motil       Date:  2005-10-14       Impact factor: 2.698

Review 3.  O-GlcNAcylation, an original modulator of contractile activity in striated muscle.

Authors:  C Cieniewski-Bernard; V Montel; L Stevens; B Bastide
Journal:  J Muscle Res Cell Motil       Date:  2010-02-25       Impact factor: 2.698

4.  Ca²⁺ sensitization of cardiac myofilament proteins contributes to exercise training-enhanced myocardial function in a porcine model of chronic occlusion.

Authors:  Vandana Sarin; Mariappan Muthuchamy; Cristine L Heaps
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-08-19       Impact factor: 4.733

5.  Phosphoprotein abundance changes in hypertensive cardiac remodeling.

Authors:  Kumar Kotlo; Keven R Johnson; Jean M Grillon; David L Geenen; Pieter deTombe; Robert S Danziger
Journal:  J Proteomics       Date:  2012-05-31       Impact factor: 4.044

6.  NIMA-related kinase 9 regulates the phosphorylation of the essential myosin light chain in the heart.

Authors:  Marion Müller; Rose Eghbalian; Jes-Niels Boeckel; Karen S Frese; Jan Haas; Elham Kayvanpour; Farbod Sedaghat-Hamedani; Maximilian K Lackner; Oguz F Tugrul; Thomas Ruppert; Rewati Tappu; Diana Martins Bordalo; Jasmin M Kneuer; Annika Piekarek; Sabine Herch; Sarah Schudy; Andreas Keller; Nadja Grammes; Cornelius Bischof; Anna Klinke; Margarida Cardoso-Moreira; Henrik Kaessmann; Hugo A Katus; Norbert Frey; Lars M Steinmetz; Benjamin Meder
Journal:  Nat Commun       Date:  2022-10-20       Impact factor: 17.694

7.  In vitro rescue study of a malignant familial hypertrophic cardiomyopathy phenotype by pseudo-phosphorylation of myosin regulatory light chain.

Authors:  Priya Muthu; Jingsheng Liang; William Schmidt; Jeffrey R Moore; Danuta Szczesna-Cordary
Journal:  Arch Biochem Biophys       Date:  2013-12-26       Impact factor: 4.013

8.  Therapeutic potential of AAV9-S15D-RLC gene delivery in humanized MYL2 mouse model of HCM.

Authors:  Sunil Yadav; Chen-Ching Yuan; Katarzyna Kazmierczak; Jingsheng Liang; Wenrui Huang; Lauro M Takeuchi; Rosemeire M Kanashiro-Takeuchi; Danuta Szczesna-Cordary
Journal:  J Mol Med (Berl)       Date:  2019-05-17       Impact factor: 4.599

9.  The effect of myosin RLC phosphorylation in normal and cardiomyopathic mouse hearts.

Authors:  Priya Muthu; Katarzyna Kazmierczak; Michelle Jones; Danuta Szczesna-Cordary
Journal:  J Cell Mol Med       Date:  2012-04       Impact factor: 5.310

10.  Myosin regulatory light chain (RLC) phosphorylation change as a modulator of cardiac muscle contraction in disease.

Authors:  Christopher Toepfer; Valentina Caorsi; Thomas Kampourakis; Markus B Sikkel; Timothy G West; Man-Ching Leung; Sara A Al-Saud; Kenneth T MacLeod; Alexander R Lyon; Steven B Marston; James R Sellers; Michael A Ferenczi
Journal:  J Biol Chem       Date:  2013-03-25       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.